Global Chemotherapy-Induced Peripheral Neuropathy Market

Table of Content

1. Introduction
   • Definition of Chemotherapy Induced Peripheral Neuropathy Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Chemotherapy Induced Peripheral Neuropathy Market, By Drug Class
   • Steroids
   • Antidepressants
   • Anti-seizure
   • Narcotics
5. Chemotherapy Induced Peripheral Neuropathy Market, By Distribution Channel
   • Hospital Pharmacy
   • Retail Pharmacy
   • Online Pharmacy
6. Chemotherapy Induced Peripheral Neuropathy Market, By Geography
   • North America
     • United States
     • Canada
   • Europe
     • United Kingdom
     • Germany
     • France
     • Spain
     • Italy
     • Rest of Europe
   • Asia-Pacific
     • China
     • Japan
     • India
     • South Korea
     • Australia
     • Rest of Asia-Pacific
   • Latin America
     • Brazil
     • Mexico
     • Rest of Latin America
   • Middle East & Africa
     • Saudi Arabia
     • United Arab Emirates
     • South Africa
     • Rest of Middle East & Africa
7. Competitive Landscape
8. Company Profiles
   • Regenacy Pharmaceuticals, Inc.
     • Company Overview
     • Product Portfolio and Description
     • Key Highlights
     • Financial Overview
   • Asahi Kasei Pharma Corporation
   • Novaremed
   • Makscientific, Llc
   • Wex Pharmaceuticals Inc.
   • Sova Pharmaceuticals, Inc.
   • Kineta, Inc.
   • Aptinyx Inc.
   • Apexian Pharmaceuticals, Inc.
   • Winsantor, Inc.
9. Conclusion and Future Outlook
10. Appendix
    • Research Methodology
    • About the Pharmanucleus
11. Disclaimer